Expert panel compares opioid epidemic to early days of HIV epidemic

July 13, 2018

Annals of Internal Medicine Tip Sheet

Below please find a summary of a new article that will be published online in Annals of Internal Medicine. The summaries is not intended to substitute for the full article as a source of information.

Expert panel compares opioid epidemic to early days of HIV epidemic

Panelists recommends 5 steps for treating opioid abuse and its intersecting epidemics

Abstract: http://annals.org/aim/article/doi/10.7326/M18-1203
URLs go live when the embargo lifts

Experts are drawing on lessons learned from the early days of the HIV epidemic to address the current opioid epidemic. As a result of widespread opioid abuse, new epidemics of hepatitis C virus (HCV) and HIV infection have arisen and hospitalizations for related infections have increased. An expert panel convened by the National Academies of Sciences, Engineering, and Medicine (NASEM) recommends five crucial steps for clinicians treating patients affected by opioid addiction and these intersecting infections. The NASEM workshop proceedings will be published on July 13th and the action steps recommended by three of the planning committee members are published in Annals of Internal Medicine.

Optimal treatment of new epidemics of HCV, HIV, and other infections is often impeded by untreated opioid use disorder and few health care providers have the resources and expertise to handle these complex cases. As such, The U.S. Department of Health and Human Services (HHS) requested the NASEM convene a workshop where a panel of experts could outline action steps for addressing the intersecting epidemics of opioid use disorder and its infectious disease consequences.

The experts identified parallels between the current opioid epidemic and the early days of the HIV epidemic. Care of HIV-infected patients benefited greatly from the development of a highly trained interdisciplinary workforce partnering across treatment settings and specialties. With these lessons in mind, the panelists agreed upon five action steps for clinicians. Included in the action steps are recommendations for increasing access to addiction care and funding to states to provide effective medications to treat OUD. The experts also recommend the development of hospital-based protocols to link patients directly to community-based treatment upon discharge from the hospital.
-end-
Media contact: For an embargoed PDF, please contact Lauren Evans at laevans@acponline.org. To interview the lead author, Sandra Springer, MD, please contact Ziba Kashef at ziba.kashef@yale.edu.

American College of Physicians

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.